Injective (INJ) news
Latest Injective (INJ) news from around the world: price drivers, upgrades, listings, regulation and major deals. Also searched as: injective, inj.
21Shares Refines Injective ETF Plans: Nasdaq Listing, FTSE Index, 40–60% Staking
Why it matters: An ETF would broaden institutional access to INJ, a token with a market cap under $800 million, though approval timing remains unclear.
Injective completes first on-chain trade finance pilot with POSCO International and LG CNS
Why it matters: Tokenizing trade finance, a $5 trillion annual market, opens a major RWA market and attracts institutional players.
Injective approves Meridian upgrade with 99% support
Why it matters: Injective is making compliance part of the protocol, which could attract institutional RWA issuance and boost demand for INJ for fees and governance.
Injective to hold onchain commerce event with Microsoft before Token2049
Why it matters: Strengthening the link between AI agents and blockchain with Microsoft's backing could attract developers and capital to the Injective ecosystem.
RAY jumps 26% to $1.85, then retreats below $1.80
Why it matters: Holding $1.80 is needed for further upside, otherwise a pullback to $1.64–1.66 is likely amid seller dominance.
INJ rises 14.4% to $7.53 after Solana launch and ETF filing update
Why it matters: The Solana launch and ETF filing expand access to INJ and could support demand for the token.
INJ jumps 17% on 21Shares ETF filing update and Phantom integration
Why it matters: A potential staking ETF strengthens Injective's institutional narrative, but no approval or launch date has been set.
SEC receives updated 21Shares spot Injective ETF filing
Why it matters: Expanding the lineup of U.S. spot crypto ETFs to altcoins strengthens institutional access to INJ.
INJ Surges 20% to $7.11, Returning to May High Zone
Why it matters: A breakout above $7.40 would cancel the bearish double-top scenario, while a rejection at $7.30 with a high share of futures could trigger a sharp correction.
INJ rises 19.79% to $6.62 after Solana network launch
Why it matters: Multichain expansion boosts demand for INJ, but overbought RSI and stochastic readings risk a pullback to $5.89.
Solana rises 6% to $106 after Fed rate hike shock
Why it matters: Solana's rise depends on institutional inflows and regulatory clarity; a break above $110 would confirm the bullish scenario, while a drop below the 200-day EMA would revive the risk of $90.
Jupiter adds INJ swaps for SOL and SPL tokens on Solana
Why it matters: It expands access to INJ for Solana users and strengthens Injective's cross-chain infrastructure without wrapped tokens.
INJ launches on Solana as SPL token via Sunrise and Backpack Securities
Why it matters: A native listing without bridges simplifies access to INJ for Solana users and expands its use in the network's DeFi strategies.
INJ falls 10.2% after CLARITY Act fails and $637M in liquidations
Why it matters: INJ is losing momentum along with the broader market; holding the $5.26 zone will determine whether the rebound continues or a deeper correction begins.
INJ plunges 12% to $5.36 amid CLARITY Act failure
Why it matters: The CLARITY Act failure intensified risk-off and long liquidations; for INJ, holding the $4.96-5.03 level is crucial, otherwise a move to $4.42 is possible.
Injective: RWA perpetual volume hits $215M in 30 days
Why it matters: Growth in synthetic equity and commodity trading on-chain shows the RWA segment shifting from tokenized bonds to active derivatives, boosting network fees and demand for INJ.
INJ Plunges 12% to $5.42 Amid Mass Altcoin Liquidations
Why it matters: INJ's decline reflects broad altcoin weakness after the CLARITY Act failure and a wave of liquidations; holding $5.33 will determine the next move.
INJ rises 7.21% to $6.32 on above-average volume
Why it matters: INJ's rally is vulnerable: the outcome of the CLARITY Act vote and the Fed decision this week could quickly reverse the move.
Injective activates IIP-677 mainnet upgrade with RWA tokenization platform
Why it matters: Injective is betting on regulatory compliance as a competitive edge in the growing real-world asset tokenization segment.